MoonLake Immunotherapeutics — SCHEDULE 13G Filings
4 SCHEDULE 13G filings on record
This page lists all SCHEDULE 13G filings submitted to the SEC by MoonLake Immunotherapeutics (MLTX), sorted by most recent first. Each row links to the full filing on EdgarLookup. MoonLake Immunotherapeutics has filed 4 SCHEDULE 13G documents with the SEC since 2020. To view all SEC filings by MoonLake Immunotherapeutics, see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
144
3
4
424B3
424B4
424B5
425
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DEFM14A
DEFR14A
DRS
EFFECT
NT 10-Q
POS AM
PREM14A
PRER14A
S-1
S-1/A
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G | — | 0001172661-26-001033 | Feb 17, 2026 | — |
| SCHEDULE 13G | — | 0001172661-25-004733 | Nov 12, 2025 | — |
| SCHEDULE 13G | — | 0000902664-25-003575 | Aug 14, 2025 | — |
| SCHEDULE 13G | — | 0000080255-25-000208 | Feb 14, 2025 | — |